Search research articles
Contact Us
Filters
Showing results (61-70 of 99) with videos related to
Page
of 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 2, 2024
Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients
Lora D Thomas, Einas Batarseh, Lubna Hamdan, et al.
Journal of Clinical Pharmacology
|
June 25, 2021
Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study
Selwyn J Hurwitz, Sijia Tao, Christina Gavegnano, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 7, 2014
Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohort
H Nina Kim, Carla V Rodriguez, Stephen Van Rompaey, et al.
The Journal of Infectious Diseases
|
July 10, 2020
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus
Edgar T Overton, Amy Kantor, Kathleen V Fitch, et al.
AIDS (London, England)
|
September 16, 2024
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV
Edgar T Overton, Amy Kantor, Kathleen V Fitch, et al.
Open Forum Infectious Diseases
|
December 10, 2021
Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus
Emma M Kileel, Janet Lo, Carlos Malvestutto, et al.
The Journal of Infectious Diseases
|
May 10, 2022
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy
Márton Kolossváry, Chris deFilippi, Michael T Lu, et al.
Open Forum Infectious Diseases
|
December 10, 2021
A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy
Rachel M Presti, Eunice Yeh, Brett Williams, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 30, 2021
Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
Cynthia L Gay, Ronald J Bosch, Ashley McKhann, et al.
Plos One
|
December 6, 2017
Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS)
Aditi Shendre, Howard W Wiener, Marguerite R Irvin, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 99) with videos related to
Sort By:
Page
of 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 2, 2024
Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients
Lora D Thomas, Einas Batarseh, Lubna Hamdan, et al.
Journal of Clinical Pharmacology
|
June 25, 2021
Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study
Selwyn J Hurwitz, Sijia Tao, Christina Gavegnano, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 7, 2014
Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohort
H Nina Kim, Carla V Rodriguez, Stephen Van Rompaey, et al.
The Journal of Infectious Diseases
|
July 10, 2020
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus
Edgar T Overton, Amy Kantor, Kathleen V Fitch, et al.
AIDS (London, England)
|
September 16, 2024
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV
Edgar T Overton, Amy Kantor, Kathleen V Fitch, et al.
Open Forum Infectious Diseases
|
December 10, 2021
Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus
Emma M Kileel, Janet Lo, Carlos Malvestutto, et al.
The Journal of Infectious Diseases
|
May 10, 2022
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy
Márton Kolossváry, Chris deFilippi, Michael T Lu, et al.
Open Forum Infectious Diseases
|
December 10, 2021
A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy
Rachel M Presti, Eunice Yeh, Brett Williams, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 30, 2021
Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
Cynthia L Gay, Ronald J Bosch, Ashley McKhann, et al.
Plos One
|
December 6, 2017
Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS)
Aditi Shendre, Howard W Wiener, Marguerite R Irvin, et al.
Page
of 10